Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Aug 12;14(1):30.
doi: 10.1186/s12947-016-0072-5.

Echocardiographic diagnosis of the different phenotypes of hypertrophic cardiomyopathy

Affiliations
Review

Echocardiographic diagnosis of the different phenotypes of hypertrophic cardiomyopathy

Vito Maurizio Parato et al. Cardiovasc Ultrasound. .

Abstract

Hypertrophic Cardiomyopathy (HCM) is an inherited cardiovascular disorder of great genetic heterogeneity and has a prevalence of 0.1 - 0.2 % in the general population. Several hundred mutations in more than 27 genes, most of which encode sarcomeric structures, are associated with the HCM phenotype. Then, HCM is an extremely heterogeneous disease and several phenotypes have been described over the years. Originally only two phenotypes were considered, a more common, obstructive type (HOCM, 70 %) and a less common, non-obstructive type (HNCM, 30 %) (Maron BJ, et al. Am J Cardiol 48:418 -28, 1981). Wigle et al. (Circ 92:1680-92, 1995) considered three types of functional phenotypes: subaortic obstruction, midventricular obstruction and cavity obliteration. A leader american working group suggested that HCM should be defined genetically and not morphologically (Maron BJ, et al. Circ 113:1807-16, 2006). The European Society of Cardiology Working Group on Myocardial and Pericardial Diseases recommended otherwise a morphological classification (Elliott P, et al. Eur Heart J 29:270-6, 2008). Echocardiography is still the principal tool for the diagnosis, prognosis and clinical management of HCM. It is well known that the echocardiographic picture may have a clinical and prognostic impact. For this reason, in this article, we summarize the state of the art regarding the echocardiographic pattern of the HCM phenotypes and its impact on clinical course and prognosis.

Keywords: Cardiomiopathy; Echocardiography; Hypertrophy.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
The four phenotypes of Maron’s classification (1981) (from reference 21)
Fig. 2
Fig. 2
a PLAX view demonstrating the asymmetrical hypertrophy of the interventricular septum over the posterior wall with a ratio >1.3. b Massive septal hypertrophy characterized by a septal diastolic thickness > 30 mm. c Massive septal hypertrophy with RVOT obstruction by the projection of the massively hypertrophied interventricular septum into the right outflow tract. d MOHC with the ‘hourglass’ shaped left ventricle consisting of two different chambers: the proximal and the distal chamber
Fig. 3
Fig. 3
PLAX M-mode of SAM documented by the contact of the anterior mitral valve leaflet/chordae with the septum
Fig. 4
Fig. 4
e 3DTTE imaging of LV apical aneurysm (from ref. 36). f TTE imaging of non massive apical HCM picture. g TTE imaging of massive apical HCM characterized by a systolic cavity obliteration. h Asymmetric LV posterior wall hypertrophy (from ref. 59)

Similar articles

Cited by

References

    1. Elliott PM, Anastasakis A, Borger MA, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC) Eur Heart J. 2014;35(39):2733–2779. doi: 10.1093/eurheartj/ehu284. - DOI - PubMed
    1. Maron BJ, Towbin JA, Thiene G, et al. American Heart Association; Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups, Council on Epidemiology and Prevention. Circulation. 2006;113:1807–1816. doi: 10.1161/CIRCULATIONAHA.106.174287. - DOI - PubMed
    1. Elliott P, Andersson B, Arbustini E, et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2008;29:270–276. doi: 10.1093/eurheartj/ehm342. - DOI - PubMed
    1. Rapezzi C, Arbustini E, Caforio AL, et al. Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34:1448–1458. doi: 10.1093/eurheartj/ehs397. - DOI - PubMed
    1. Maron BJ. The electrocardiogram as diagnostic tool for hypertrophic cardiomyopathy: Revisited [editorial] Ann Noninvas Electrocardiol. 2001;6:277–279. doi: 10.1111/j.1542-474X.2001.tb00118.x. - DOI - PMC - PubMed

LinkOut - more resources